CAIROLI, ROBERTO

CAIROLI, ROBERTO  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 311 (tempo di esecuzione: 0.034 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination.—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda 01 - Articolo su rivista 2024 Cairoli, Roberto +
Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients 01 - Articolo su rivista 2024 Zappaterra, AriannaCivettini, IvanPierini, SilviaGambacorti-Passerini, CarloCairoli, Roberto +
Cerebral Infectious Opportunistic Lesions in a Patient with Acute Myeloid Leukaemia: The Challenge of Diagnosis and Clinical Management 01 - Articolo su rivista 2024 Cavazza, GabrieleDi Gennaro, ElisaPeracchi, FrancescoMonti, BiancaCorti, NicolòCairoli, RobertoPuoti, Massimo +
Communicating the diagnosis of a hematological neoplastic disease to patients’ minor children: a multicenter prospective study 01 - Articolo su rivista 2024 Antolini, LauraMantegazza, RaffaeleCairoli, RobertoGambacorti Passerini, Carlo +
Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3 01 - Articolo su rivista 2024 Cairoli, Roberto +
Hypoplasia of the Spleen: Rare and Puzzling 01 - Articolo su rivista 2024 Cairoli R. +
Lymphoma’s last therapeutic option: Freeze it! 01 - Articolo su rivista 2024 Bassi, GFerrari, MBCairoli, R +
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial 01 - Articolo su rivista 2024 Cairoli R. +
A Nine-Gene Expression Signature Distinguished a Patient with Chronic Lymphocytic Leukemia Who Underwent Prolonged Periodic Fasting 01 - Articolo su rivista 2023 Cairoli, Roberto +
Assessing eligibility for treatment in acute myeloid leukemia in 2023 01 - Articolo su rivista 2023 Cairoli, Roberto +
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia 01 - Articolo su rivista 2023 Cairoli R +
Cordycepin (3′dA) Induces Cell Death of AC133+ Leukemia Cells via Re-Expression of WIF1 and Down-Modulation of MYC 01 - Articolo su rivista 2023 Cairoli, R +
Cost-effectiveness analysis of gemtuzumab ozogamicin for the treatment of de novo CD33-positive Acute Myeloid Leukaemia (AML) in Italy 01 - Articolo su rivista 2023 Cairoli R +
Current Treatment Options and the Role of Functional Status Assessment in Classical Hodgkin Lymphoma in Older Adults: A Review 01 - Articolo su rivista 2023 Cairoli, Roberto +
Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an "Old-fashioned" Drug be Effective? 01 - Articolo su rivista 2023 Cairoli, Roberto +
Dual antiviral therapy in haematological patients with protracted SARS-CoV-2 infection 01 - Articolo su rivista 2023 Peracchi, FPuoti, MCairoli, R +
MIS-A: Beware of non-lymphoma 01 - Articolo su rivista 2023 Cairoli, R +
Multidimensional Results and Reflections on CAR-T: The Italian Evidence 01 - Articolo su rivista 2023 Cairoli R +
Multiparametric Flow Cytometry-MRD Assay: Lesson from Phase II Trail REL AML 001 02 - Intervento a convegno 2023 Cairoli, Roberto +
Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS) 02 - Intervento a convegno 2023 Palumbo, CassandraCairoli, Roberto +